Cambrex Corp. (CBM) Stock Quote

Detailed Quote for Cambrex Corp. (CBM) 
$ 7.04   0.20 (+2.92%) Volume: 182.41 k 1:37 PM EST Feb 10, 2012
Today 5d 1m 3m 1y more
Last Price
7.04
Change $
0.20
Change %
2.92%
Tick
  
Bid
7.00
Bid Size
700
Ask
7.03
Ask Size
300
Open
6.76
High
7.10
Low
6.74
Prev Close
6.84
Last Trade
1:37
Volume
182.41 k
52 Wk Hi
8.44
52 Wk Low
3.87
Market Cap
208.22 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
29,576,880
EPS (TTM)
0.37
PE Ratio
18.50
Exchange
NYE
News and Media for Cambrex Corp.  (CBM) 
Sector News | Topic News
News for CBM
Mon, Feb 06, 2012
4:23 PM Cambrex Reports Fourth Quarter and Full Year 2011 Results - PR Newswire
3:34 PM Cambrex to Present at UBS 22nd Annual Global Healthcare Services Conference - PR Newswire
Thu, Feb 02, 2012
9:57 AM Cambrex to Announce Fourth Quarter 2011 Financial Results on February 6, 2012 - PR Newswire
Thu, Nov 03, 2011
4:11 PM Cambrex Reports Third Quarter 2011 Results - PR Newswire
Tue, Nov 01, 2011
8:37 AM Cambrex to Announce Third Quarter 2011 Financial Results on November 3, 2011 - PR Newswire
Thu, Jan 22, 2009
9:31 AM Skinvisible and Cambrex Enter Into Agreement to Develop Acne Products - Canada Newswire
More News for CBM >>

Tags for Cambrex Corp.

Research stocks or mutual funds related to Cambrex Corp. by keywords or tags. Find companies that have a similar focus to CBM. The keywords below have been associated to CBM by either user submission or electronic means.

pharmaceutical sales data pharmaceutical gmp cambrex corp ich pharmaceutical pharmaceutical data biotech research purdue pharma pharmaceutical branding pharmaceutical industry strategy sterility testing pharmaceutical validation pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment niche pharmaceutical pharmaceutical inserts siebel pharma pharmaceutical training financial annual report merck pharmaceutical sales pharma regulations pharmaceutical research and development annual report pharmaceutical manufacturing company Biological Products pharma marketing pharmaceutical industry marketing pharma newsletter bioburden testing pharmaceutical tank pharma industry research pharmaceutical software pharma manufacturing pharmaceutical market share pharmaceutical qc pharmaceutical quality control pharma license kv pharmaceutical company pharmaceutical ingredients china pharma pharmaceutical cro pharma companies ap pharma pharma consulting aventis corporation active pharmaceutical ingredients pharmaceutical sales pharma pharmaceutical distributors

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.